Laos - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Laos Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 16.3% year on year. In 2019, the country was number 181 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 51 Cases. India lead the ranking with 66,255 Cases in 2019, a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 51.00 |
| 2018 | 52.00 |
| 2017 | 38.00 |
| 2016 | 44.00 |
| 2015 | 33.00 |
Download all data from 2010 to 2019
How does Laos rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 180 |
#180
Iran
|
52 | 2019 | +0.0 % | +1.6 % | View data | |
| 181 |
#181
Laos
|
51 | 2019 | -1.9 % | +16.3 % | View data | |
| 181 |
#181
Poland
|
51 | 2019 | +0.0 % | +0.8 % | View data | |